{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000033","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.197183+00:00","generated_at":"2026-05-24T23:44:18.717394+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"confidence":"high","headline":"Salarius Pharmaceuticals files prospectus supplement for ATM offering of up to $417,000","bullets":["Filed prospectus supplement on March 10, 2025 for at-the-market offering of up to $417,000 of common stock.","Offering conducted through Ladenburg Thalmann & Co. under existing S-3 registration statement (333-266589).","Legal opinion from Hogan Lovells US LLP included as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000033","json":"https://secwatch.observer/filing/0001615219-25-000033.json","markdown":"https://secwatch.observer/filing/0001615219-25-000033.md","text":"https://secwatch.observer/filing/0001615219-25-000033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000033/0001615219-25-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000033/flks-20250310.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T23:44:18.717394+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}